Pharmacokinetics and pharmacodynamics in the critically ill child

Athena F Zuppa1, Jeffrey S Barrett

  • 1The Children's Hospital of Philadelphia, Abramson Research Center, 3516 Civic Center Boulevard, Suite 916 H, Philadelphia, PA 19104, USA. zuppa@email.chop.edu

Insights

Understanding pharmacokinetics and pharmacodynamics is crucial for prescribing medications to critically ill children. Age and disease significantly impact drug absorption, distribution, metabolism, elimination, and response, necessitating careful consideration of adult dosing data.

Area of Science:

  • Pediatric critical care medicine
  • Clinical pharmacology

Background:

  • Pharmacokinetics and pharmacodynamics (PK/PD) are essential for rational drug prescribing.
  • Drug disposition and effects are influenced by patient age and disease severity.
  • Critically ill children often receive medications based on adult data.

Purpose of the Study:

  • To highlight the importance of PK/PD in pediatric critical care.
  • To emphasize factors affecting drug therapy in critically ill children.
  • To caution against the extrapolation of adult dosing regimens.

Main Methods:

  • Review of PK/PD principles in pediatric populations.
  • Analysis of factors influencing drug absorption, distribution, metabolism, and elimination.
  • Examination of medication use in pediatric intensive care settings.

Main Results:

  • Age and disease state significantly alter PK/PD parameters in children.
  • Adult dosing guidelines may not be appropriate for critically ill pediatric patients.
  • High risk of drug interactions and adverse events exists in pediatric intensive care.

Conclusions:

  • A rational approach to pediatric critical care pharmacotherapy requires understanding PK/PD.
  • Careful patient assessment is needed to optimize drug therapy.
  • Vigilance for drug interactions and adverse reactions is paramount.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...